Immunotherapy is a type of treatment against cancer by activating or suppressing a patient’s own immune system. There are several types of immunotherapies, including monoclonal antibodies, T-cell transfer therapy, non-specific immunotherapies, oncolytic virus therapy, and treatment vaccines. These therapies can be used throughout different stages of cancer care, from metastatic to adjuvant phases.

ADCs for ES-SCLC. Image credit: DOI: 10.3390/genes15060701Extensive-stage small-cell lung cancer (ES-SCLC) is a particularly aggressive form of lung cancer characterized by rapid growth and early metastasis. Antibody drugs, especially immune checkpoint inhibitors, have emerged as a promising treatme

Discover cancer immunotherapy techniques like monoclonal antibodies, checkpoint inhibitors, & ADCs. Learn how targeted delivery & tumor selectivity improve cancer treatment.

The 20th Annual PEGS Boston Summit 2024 was held in Boston, MA from May 13-17. During the event, industry experts from across the world gathered to share the latest research in advancements in drug development, protein and antibody engineering, immunotherapy, immunogenicity, expression platforms, mu

Here at the AACR Annual Meeting 2024, there are over 7000 abstracts, 300 poster presentations, and 50 symposia all about cancer research. A few topics that are currently trending in the conference include cancer vaccines, AI for diagnostics, novel immunotherapies, and antibody-drug conjugates (ADCs) as a new modality.

Discover how antibodies revolutionize immunotherapy by targeting cancer cells, triggering immune responses, and advancing treatments for cancer and other diseases.